Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Tirzepatide is a synthetic dual incretin receptor agonist that targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is designed to support metabolic regulation through multiple hormonal pathways involved in insulin secretion, glucose control, and appetite signaling.
By activating both receptors, tirzepatide represents a dual-mechanism approach within the incretin-based therapeutic class.
Tirzepatide is a synthetic dual incretin receptor agonist that targets both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is designed to support metabolic regulation through multiple hormonal pathways involved in insulin secretion, glucose control, and appetite signaling.
By activating both receptors, tirzepatide represents a dual-mechanism approach within the incretin-based therapeutic class.